Cite
HARVARD Citation
Fury, M. et al. (2013). A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer. Cancer. 119 (10), pp. 1823-1831. [Online].